Targeted expression of human O6-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis

Cancer Research

Volumn 56, Issue 14, 1996, Pages 3244-3249

  Becker, Klaus ^a   Dosch, Jörg ^b   Gregel, Cornelia M ^a   Martin, Brian A ^a   Kaina, Bernd ^b  

^a LEIBNIZ INSTITUTE OF PLANT GENETICS AND CROP PLANT RESEARCH IPK   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; DNA METHYLTRANSFERASE;

ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; DNA REPAIR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RNA ANALYSIS; SKIN CARCINOGENESIS; TRANSGENIC MOUSE;

ANIMALS; DNA REPAIR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; KERATINS; METHYLNITROSOUREA; METHYLTRANSFERASES; MICE; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PAPILLOMA; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SKIN NEOPLASMS; TRANSGENES;

EID: 0029901710     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. DiGiovanni, J. Multistage carcinogenesis in mouse skin. Pharmacol. Ther , 54: 63-128, 1992.
2. Marks, F., and Fürstenberger, G. From the normal cell to cancer: The multistep process of experimental skin carcinogenesis. In: A. P. Maskens, P. Ebbesen, and A. Burny (eds.), Concepts and Theories in Carcinogenesis, pp. 169-184. Amsterdam Elsevier Science Publishers Amsterdam, 1987.
3. Yuspa, S H , and Poirier, M C. Chemical carcinogenesis: from animal models to molecular models in one decade. Adv. Cancer Res., 50: 25-70, 1988
4. Slaga, T J. Mechanisms involved in multistage skin carcinogenesis. Carcinog Compr. Surv., 11: 1-18, 1989.
5. Fürstenberger, G., Schurich, B., Kaina, B., Petrusevska, R. T , Fusenig, N. E , and Marks, F. Tumor induction in initiated mouse skin by phorbol esters and methyl methanesulfonate: correlation between chromosomal damage and conversion ("stage I of tumor promotion") in vivo. Carcinogenesis (Lond), 10: 749-752, 1989.
6. Kemp, C J , Burns, P. A., Brown, K , Nagase, H , and Balmain, A Transgenic approaches to the analysis of ras and p53 function in multistage carcinogenesis. Cold Spring Harbor Symp. Quant. Biol , 59: 427-434, 1994
7. Yuspa, S H The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis - Thirty-third G. H. A Clowes Memorial Award Lecture. Cancer Res., 54: 1578-1189, 1994.
8. Yuspa, S. H. Carcinogenesis: chemical In: T. B. Fitzpatrick, A. Z Eisen, K. Wolff, I. M Freedberg, and K. F. Austen (eds.), Dermatology in General Medicine, pp 722-729 New York McGraw-Hill, 1987.
9. Miller, S J. Biology of basal cell carcinoma (part I). J. Am. Acad. Dermatol, 24 1-16, 1991
10. Graffi, A., Hoffmann, F , and Schütt, M. N-Methyl-N-nitrosourea as a strong topical carcinogen when painted on skin of rodents Nature (Lond.), 214 611, 1967.
11. Waynforth, H. B., and Magee, P. N. The effect of various doses and schedules of administration of N-methyl-N-nitrosourea, with and without croton oil promotion, on skin papilloma production in BALB/c mice. GANN Monogr Cancer Res , 17: 439-448, 1975.
12. Lijinski, W., and Reuber, M. D. Neoplasms of the skin and other organs observed in Swiss mice treated with nitrosoalkylureas J. Cancer Res Clin. Oncol , 114: 245-249, 1988.
13. Lijinski, W., Thomas, B. J., and Kovatch, R. M. Differences in skin carcinogenesis by methylnitrosourea between mice of several strains. Cancer Lett , 61: 1-5, 1991.
14. 6-alkylation of deoxyguanosine to the mutagenicity and carcinogenicity of nitrosamines and nitrosamides. Nature (Lond), 223: 206-207, 1969.
15. 6-methylguanine in template DNA during in vitro DNA replication J. Biol. Chem., 259: 8095-8100, 1984.
16. 6-methylguanine built into a unique site in a viral genome. Proc. Natl Acad. Sci USA, 81 6271-6275, 1984.
17. Saffhill, R., Margison, G P , and O'Connor, P J Mechanisms of carcinogenesis induced by alkylating agents Biochim Biophys. Acta, 823: 111-145, 1985.
18. 6-methylguanine-DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis (Lond.), 5 1641-1647, 1984.
19. 6-methylguanine in cell killing and mutagenesis in Chinese hamster ovary cells Carcinogenesis (Lond.), 12: 83-89, 1991.
20. Karran, P., and Bignami, M. Self-destruction and tolerance in resistance of mammalian cells to alkylation damage Nucleic Acids Res., 20: 2933-2940, 1992
21. 6-alkylguanine and N-alkylpurines to the formation of sister chromatid exchanges, chromosomal aberrations, and gene mutations new insights gained from studies of genetically engineered mammalian cell lines. Environ. Mol. Mutagen, 22: 283-292, 1993
22. 6-methylguanine residues in genomic DNA and production of sister-chromatid exchanges, mutations, and lethal events in a Mer-human tumor cell line Mutat. Res., 314: 99-113, 1994.
23. 6-methylguanine in a synthetic DNA polymer by an inducible activity in Escherichia coli. Biochem Biophys. Res Commun , 97: 654-659, 1980.
24. 6-methylguanine-DNA methyltransferase. J. Biol. Chem., 257: 13776-13780, 1982
25. 6-methylguanine-DNA methyltransferase in cell survival, mutagenesis and carcinogenesis Mutat Res., 145: 1-16, 1985.
26. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents Cancer Res., 50: 6119-6129, 1990.
27. Mitra, S., and Kaina, B Regulation of repair of alkylation damage in mammalian genomes. Prog. Nucleic Acid Res Mol. Biol., 44: 109-142, 1993.
28. Brennand, J., and Margison, G. P. Reduction of the toxicity and mutagenicity of alkylating agents in mammalian cells harboring the Escherichia coli alkyltransferase gene. Proc. Natl Acad. Sci USA, 83 6292-6296, 1986.
29. 6-ethylguanine in DNA protects rat 208F cells from tumorigenic conversion by N-ethyl-N-nitrosourea Proc. Natl. Acad. Sci USA, 87: 9883-9887, 1990.
30. 6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the toxic effects of alkylating agents. Carcinogenesis (Lond), 12: 1857-1867, 1991
31. 6-alkylguanine-DNA alkyltransferase. Science (Washington DC), 259: 219-222, 1993
32. 6-methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis. Proc. Natl. Acad. Sci. USA, 90: 6468-6472, 1993.
33. Gerson, S L., Zaidi, N. H., Dumenco, L. L , Allay, E., Fan, C. Y., Liu, L , and O'Connor, P J. Alkyltransferase transgenic mice: probes of chemical carcinogenesis. Mutat. Res., 307: 541-555, 1994.
34. 6-alkylguanine Proc. Natl. Acad. Sci. USA, 87: 686-690, 1990.
35. Blessing, M, Nanney, L B., King, L. E , Jones, C. M , and Hogan, B L. M Transgenic mice as a model to study the role of TGF-β-related molecules in hair follicles. Genes Dev., 7: 204-215, 1993
36. Hogan, B. L M., Beddington, R., Costantini, F., and Lacy, E. Manipulating the Mouse Embryo. A Laboratory Manual, 2nd ed Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1994.
37. Chomczynski, P , and Sacchi, N. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem., 162: 156-159, 1987.
38. 6-methylguanine-DNA methyltransferase activity in breast and brain tumors. Int. J. Cancer, 61: 321-326, 1995.
39. Blessing, M , Nanney, L B., King, L. E , and Hogan, B. L. M Chemical skin carcinogenesis is prevented in mice by the induced expression of a TGF-β related transgene Teratog. Carcinog. Mutagen., 15: 11-21, 1995.
40. Slaga, T. J., Fischer, S. M , Nelson, K., and Gleason, G L. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. Proc. Natl. Acad. Sci USA, 77: 3659-3663, 1980
41. Furstenberger, G , and Marks, F. Growth stimulation and tumor promotion in skin. J. Invest. Dermatol , 81: 157s-161s, 1983.
42. Dipple, A , Pigott, M. A., Bigger, C. A. H , and Blake, D. M. 7,12-Dimethylbenz-(a)anthracene-DNA binding in mouse skin response of different mouse strains and effects of various modifiers of carcinogenesis. Carcinogenesis (Lond), 5: 1087-1090, 1984
43. Quintanilla, M., Brown, K., Ramsden, M., and Balmain, A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature (Lond), 322: 78-80, 1986.
44. Cheng, S C., Prakash, A. S., Pigott, M. A , Hilton, B. D., Lee, H., Harvey, R G , and Dipple, A. A metabolite of the carcinogen 7,12-dimethylbenz(a)anthracene that reacts predominantly with adenine residues in DNA. Carcinogenesis (Lond.), 9: 1721-1723, 1988.
45. Moll, R, Franke, W W , Schiller, D. L., Geiger, B., and Krepler, R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell, 31 11-24, 1982
46. Fuchs, E. Keratins and the skin. Annu. Rev. Cell Dev. Biol., 11: 123-153, 1995.
47. Blessing, M., Jorcano, J. L., and Franke, W. W. Enhancer elements directing cell-type-specific expression of cytokeratin genes and changes of the epithelial cytoskeleton by transfections of hybrid cytokeratin genes EMBO J., 8: 117-126, 1989.
48. Ramirez, A., Vidal, M , Bravo, A., Larcher, F. and Jorcano, J. L. A 5′-upstream region of a bovine keratin 6 gene confers tissue-specific expression and hyperproliferation-related induction in transgenic mice. Proc Natl. Acad. Sci. USA, 92: 4783-4787, 1995.
49. Casatorres, J , Navarro, J M., Blessing, M. and Jorcano, J. L. Analysis of the control of expression and tissue specificity of the keratin 5 gene, characteristic of basal keratinocytes. J. Biol Chem , 269: 20489-20496, 1995.
50. Morris, R. J., Fischer, S. M , and Slaga, T. J Evidence that a slowly cycling subpopulation of adult murine epidermal cells retains carcinogen Cancer Res., 46: 3061-3066, 1986.
51. Bailleul, B., Surani, M. A., White, S., Barton, S. C., Brown, K., Blessing, M , and Balmain, A. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell, 62: 697-708, 1990.
52. Cotsarelis, G , Sun, T. T., and Lavker, R. M. Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell, 61: 1329-1337, 1990.
53. Zaidi, N. H., Pretlow, T. P., O'Riordan, M. A., Dumenco, L. L., Allay, E., and Gerson, S. L. Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the Ki-ras oncogene of mouse colon. Carcinogenesis (Lond), 16: 451-456, 1995.
54. Frei, J V., Swenson, D H., Warren, W , and Lawley, P D Alkylation of deoxyribonucleic acid in vivo in various organs of C57BL mice by the carcinogens N-methyl-N-nitrosourea, N-ethyl-N-nitrosourea and ethyl methanesulphonate in relation to induction of thymic lymphoma. Biochem J., 174 1031-1044, 1978.
55. 6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis (Lond.), 7: 745-749, 1986.
56. Glick, A. B, Kulkarni, A. B., Tennenbaum, T., Hennings, H., Flanders, K. C., O'Reilly, M., Sporn, M. B., Karlson, S., and Yuspa, S. H Loss of expression of transforming growth factor β in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion Proc Natl Acad. Sci. USA, 90: 6076-6080, 1993
57. Markowitz, S., Wang, J., Myeroff, L., Parsons, R , Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability Science (Washington DC), 268: 1336-1338, 1995.
58. Balmain, A , and Brown, K Oncogene activation in chemical carcinogenesis. Adv. Cancer Res., 51: 147-182, 1988.
59. Brown, K , Buchmann, A., and Balmain, A. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc. Natl. Acad. Sci. USA, 87: 538-542, 1990
60. Colvin, M The alkylating agents. In: B. Chabner (ed), Pharmacologic Principles of Cancer Treatment, pp 276-308 Philadelphia W. B. Saunders Co , 1982.
61. Avril, M-F , Bonneterre, J., Delaunay, M., Grosshans, E., Fumoleau, P., Israel, L., Bugat, R , Namer, M , Cupissol, D., Kerbrat, P., Montcuquet, P , Arcaute, V , and Bizzari, J-P. Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma, experience of the french study group. Cancer Chemother. Pharmacol., 27 81-84, 1990.
62. 6-alkylguanine-alkyltransferase (AT) in cancer chemotherapy Cancer Treat Rev , 15: 279-292, 1988.
63. Kaldor, J. M., Day, N. E., Band, P, Choi, N W., Clarke, E. A Coleman, M P , Hakama, M., Koch, M , Langmark, F , Neal, F. E., Pettersson, F , Pompe-Kirn, V , Prior, P., and Storm, H. H Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer, 39: 571-585, 1987